Author:
Venne Danielle M.,Hartley David M.,Malchione Marissa D.,Koch Michala,Britto Anjali Y.,Goodman Jesse L.
Abstract
AbstractBackgroundCarbapenem-resistant Enterobacterales are among the most serious antimicrobial resistance (AMR) threats. Emerging resistance to polymyxins raises the specter of untreatable infections. These resistant organisms have spread globally but, as indicated in WHO reports, the surveillance needed to identify and track them is insufficient, particularly in less resourced countries. This study employs comprehensive search strategies with data extraction, meta-analysis and mapping to help address gaps in the understanding of the risks of carbapenem and polymyxin resistance in the nations of Africa.MethodsThree comprehensive Boolean searches were constructed and utilized to query scientific and medical databases as well as grey literature sources through the end of 2019. Search results were screened to exclude irrelevant results and remaining studies were examined for relevant information regarding carbapenem and/or polymyxin(s) susceptibility and/or resistance amongstE. coliandKlebsiellaisolates from humans. Such data and study characteristics were extracted and coded, and the resulting data was analyzed and geographically mapped.ResultsOur analysis yielded 1341 reports documenting carbapenem resistance in 40 of 54 nations. Resistance amongE. coliwas estimated as high (> 5%) in 3, moderate (1–5%) in 8 and low (< 1%) in 14 nations with at least 100 representative isolates from 2010 to 2019, while present in 9 others with insufficient isolates to support estimates. Carbapenem resistance was generally higher amongKlebsiella: high in 10 nations, moderate in 6, low in 6, and present in 11 with insufficient isolates for estimates. While much less information was available concerning polymyxins, we found 341 reports from 33 of 54 nations, documenting resistance in 23. Resistance amongE. coliwas high in 2 nations, moderate in 1 and low in 6, while present in 10 with insufficient isolates for estimates. AmongKlebsiella, resistance was low in 8 nations and present in 8 with insufficient isolates for estimates. The most widespread associated genotypes were, for carbapenems,blaOXA-48,blaNDM-1andblaOXA-181and, for polymyxins,mcr-1,mgrB, andphoPQ/pmrAB. Overlapping carbapenem and polymyxin resistance was documented in 23 nations.ConclusionsWhile numerous data gaps remain, these data show that significant carbapenem resistance is widespread in Africa and polymyxin resistance is also widely distributed, indicating the need to support robust AMR surveillance, antimicrobial stewardship and infection control in a manner that also addresses broader animal and environmental health dimensions.
Funder
Armed Forces Health Surveillance Branch
Georgetown University Medical Center
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health
Reference792 articles.
1. World Health Organization (WHO). Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020 [Internet]. Geneva, Switzerland; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/332081/9789240005587-eng.pdf?ua=1%0Ahttp://www.who.int/glass/resources/publications/early-implementation-report-2020/en/%0Ahttp://apps.who.int/iris/bitstream/10665/188783/1/9789241549400_eng.pdf?ua=1
2. Mitgang EA, Hartley DM, Malchione MD, Koch M, Goodman JL. Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: using diverse data to inform surveillance gaps. Int J Antimicrob Agents. 2018;52(3):372–84. https://doi.org/10.1016/j.ijantimicag.2018.05.019.
3. Codjoe F, Donkor E. Carbapenem resistance: a review. Med Sci. 2017;6(1):1.
4. Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115(15):E3463–70.
5. Torres NF, Chibi B, Kuupiel D, Solomon VP, Mashamba-Thompson TP, Middleton LE. The use of non-prescribed antibiotics; prevalence estimates in low-and-middle-income countries. A systematic review and meta-analysis. Arch Public Heal. 2021;79(1):1–15.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献